Infectious Disease Management in Animal Shelters 2021
DOI: 10.1002/9781119294382.ch14
|View full text |Cite
|
Sign up to set email alerts
|

Canine Parvovirus and Other Canine Enteropathogens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(8 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…Since it is possible for puppies with PMC to not have parvovirus infection in the intestines, the use of point of care CPV-2 testing, in the absence of gastrointestinal clinical signs, may give a negative result but cannot exclude PMC. Infectious risk was considered very low since puppies had repeated negative point of care tests and no clinical signs ( 10 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since it is possible for puppies with PMC to not have parvovirus infection in the intestines, the use of point of care CPV-2 testing, in the absence of gastrointestinal clinical signs, may give a negative result but cannot exclude PMC. Infectious risk was considered very low since puppies had repeated negative point of care tests and no clinical signs ( 10 ).…”
Section: Discussionmentioning
confidence: 99%
“…In puppies, the myocardial cells are rapidly dividing in the 2 weeks just after birth and it is during this time that infection with CPV-2 can result in myocarditis ( 8 ). While reports of myocarditis are rare, parvoviral enteritis remains a significant cause of morbidity and mortality in dogs despite development of an effective vaccine ( 9 , 10 ).…”
Section: Introductionmentioning
confidence: 99%
“…In shelter settings, rapid and cost-effective screening methods are essential for early detection, isolation, and treatment of infected animals to minimise disease spread (Marques et al, 2023). Point-of-care faecal ELISA antigen testing remains the diagnostic test of choice for CPV in the shelter setting (Doyle, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…CPV, a member of the Parvoviridae family, was first recognised in 1978 (Zhao et al, 2011) and is characterised by its high stability in the environment, allowing it to persist in contaminated areas for extended periods (Doyle, 2021). This virus primarily targets the rapidly dividing cells of the gastrointestinal tract and bone marrow, leading to clinical signs such as severe gastroenteritis, dehydration, lethargy, and often a high mortality rate if left untreated (Tuteja et al, 2022).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation